EKF Diagnostics (LON:EKF – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX 1.38 ($0.02) EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%.
EKF Diagnostics Stock Down 4.2 %
Shares of LON:EKF opened at GBX 22.28 ($0.29) on Wednesday. The company has a market capitalization of £99.03 million, a price-to-earnings ratio of 20.73 and a beta of 0.57. The company has a 50 day moving average of GBX 23.30 and a two-hundred day moving average of GBX 25.88. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. EKF Diagnostics has a 52-week low of GBX 18.40 ($0.24) and a 52-week high of GBX 33.80 ($0.44).
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Recession Risk: Is It Going to Happen? Here Are the Key Clues
- Energy and Oil Stocks Explained
- Best of Both Worlds: 3 ETFs With High Dividend Yields, Low Fees
- Investing in Construction Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
